` VISTN (Vistin Pharma ASA) vs Oslo OBX Comparison - Alpha Spread

VISTN
vs
Oslo OBX

Over the past 12 months, VISTN has underperformed Oslo OBX, delivering a return of 2% compared to the Oslo OBX's 8% growth.

Stocks Performance
VISTN vs Oslo OBX

Loading

Performance Gap
VISTN vs Oslo OBX

Loading
VISTN
Oslo OBX
Difference

Performance By Year
VISTN vs Oslo OBX

Loading
VISTN
Oslo OBX
Add Stock

Competitors Performance
Vistin Pharma ASA vs Peers

Oslo OBX
VISTN
LLY
JNJ
NOVO B
ROG
Add Stock

Vistin Pharma ASA
Glance View

Market Cap
1.1B NOK
Industry
Pharmaceuticals

Vistin Pharma ASA engages in the manufacture and sale of metformin products. The company is headquartered in Oslo, Oslo. The company went IPO on 2015-06-10. The company was created as a result of spin-off of Weifa AS. The company specializes in manufacture of Active Pharmaceutical Ingredients (API) and Solid Dosage Forms. Its products portfolio is comprised of Metformin, Pholcodine and Codeine Phosphate, among others. The firm's products are sold domestically and abroad, including markets in Asia, America, Africa and Europe.

VISTN Intrinsic Value
20.6 NOK
Overvaluation 14%
Intrinsic Value
Price
V
Back to Top